European Commission New Corona Vaccine Participation in the framework for fair delivery September 1: 6:46

The European Commission, which is the executive body of EU=European Union, announced on the 31st of last month that it will participate in the framework for equitable delivery of the new coronavirus vaccine to countries around the world established by WHO=World Health Organization.

In this regard, WHO Executive Secretary Tedros has indicated that he will continue to cooperate with other countries so that all countries can get vaccines fairly.

As of the 24th of last month, 172 countries and regions, such as Japan, the United Kingdom, and Canada, are showing interest in the cooperation system that promotes the equitable distribution of vaccines launched by WHO and others. The United States etc. do not participate.



Against this backdrop, the European Commission announced on March 31 that it would contribute 400 million euros, or approximately JPY 50.5 billion in Japanese yen.



On this, WHO Executive Secretary Tedros welcomed the decision at a regular press conference held at the headquarters of Geneva, Switzerland last month and welcomed the decision, saying: "The only way to overcome the global pandemic is to cooperate. Once the vaccine is developed, we will continue to work with countries and others to ensure that all countries have equal access to it."



The WHO says it will have to confirm its will by September 18 to participate in this cooperation, and will continue to negotiate with countries that have not expressed interest.

What is the COVAX facility?

The "COVAX Facility" is an international cooperation system jointly established by WHO and an international organization working on vaccination in developing countries, in which participating countries discover and manufacture effective vaccines and distribute them fairly. It is a mechanism to share the expenses for.



This time, the European Commission, which is the executive body of the EU = European Union, has newly announced its participation in this cooperation system.



WHO and others are planning to prepare for mass production of vaccines from this stage under the cooperation system so that the supply of vaccines can be promptly started when the safety and efficacy of vaccines are confirmed.



Specifically, aiming to manufacture 2 billion doses of vaccine by the end of next year, 20% of the population will be able to receive the vaccine in each of the investing countries, and in the recipient countries, medical personnel will be prioritized. The same vaccine will be distributed.